Stay updated on Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial
Sign up to get notified when there's something new on the Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial page.

Latest updates to the Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision from v3.5.3 to v3.5.4 indicates a small update to the page or site metadata. It does not modify the study content or outcomes.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe non-diacritic Malmo, Sweden, SE-205 02 entry was removed. The diacritic-correct Malmö, Sweden, SE-205 02 entry was added to the location list.SummaryDifference0.0%

- Check35 days agoChange DetectedThe page now shows a newer ClinicalTrials.gov revision/build number (“v3.5.3”), replacing the previous (“v3.5.2”). This represents a backend/UI version bump rather than a change to the study details.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check71 days agoChange DetectedAdded revision: v3.5.0 and removed revision: v3.4.3.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial page.